ArticleFrontiers in aging neuroscience2026

Autologous SVF therapy modulates neuroinflammation in ALS: phase I trial demonstrating safety and CSF biomarker dynamics.

Ruixia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.